From brain to heart: an update on the phenotypic spectrum of SCN1B-related diseases · Lucrezia Piccicacchi, ILAE YESTowards an emulated sequential target trial design of valproate discontinuation: baseline characteristics, hospitalisations and deaths · Sneha Mary George, University of Liverpool
CPD accreditedcredits not stated; usually about 6 for 1 day
Metabolic Dysfunction-Associated Steatotic Liver Disease - treatment and prevention · Professor Matthew ArmstrongYellow and unwell - managing decompensated liver disease · Dr Dina Mansour and Dr Atit Ghoda
18 CPD creditsaccreditor not stated · as stated by the organiser
Alzheimer's disease in the era of anti-amyloid therapies: ARIA monitoring and amyloid PET evaluation · Dr Yanina BergamoImaging clinical subtypes of Alzheimer's disease: a practical MRI-PET approach · Dr Yanina Bergamo